Investigating tau proteins and their impact on brain health in Alzheimer's disease.
Tau oligomer conformers and synaptic vulnerability/resilience in AD and related disorders
This study is looking at how certain tau proteins might impact brain connections in people with Alzheimer's, with the goal of finding new ways to protect those connections and help prevent damage, especially in individuals who don’t yet show symptoms of dementia.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Med Br Galveston NIH-funded |
| Lab location | 1 site (Galveston, United States) |
| Project ID | NIH-10881915 on NIH RePORTER |
What this research studies
This research focuses on understanding how specific forms of tau proteins, known as tau oligomers, affect brain synapses in Alzheimer's disease and related disorders. By examining the relationship between these tau oligomers and synaptic health, the study aims to identify potential therapeutic strategies that could prevent or mitigate synaptic damage. The research will explore the molecular mechanisms behind synaptic vulnerability and resilience, particularly in individuals who show no dementia symptoms despite having Alzheimer's-related brain changes. This approach could lead to innovative treatments targeting early disease processes.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's disease or related dementias, particularly those in the early stages of the disease.
Not a fit: Patients with advanced Alzheimer's disease or those who do not have any form of dementia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that protect brain function and improve quality of life for individuals with Alzheimer's disease.
How similar studies have performed: Previous research has shown promise in targeting tau proteins for therapeutic interventions, indicating that this approach could be a viable strategy for treating Alzheimer's disease.
Where this research is happening
Galveston, United States
- University of Texas Med Br Galveston — Galveston, United States (Active)
Researchers
- Principal investigator: Taglialatela, Giulio — University of Texas Med Br Galveston
- Study coordinator: Taglialatela, Giulio
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.